HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Cengiz Köksal Sabit Sarikaya Permission Requests Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Köksal, C. Articles by Zengin, M. Search for Related Content PubMed PubMed Citation Articles by Köksal, C. Articles by Zengin, M. Related Collections Great vessels

Thoracofemoral Bypass for Treatment of Juxtarenal Aortic Occlusion

Department of Cardiovascular Surgery Sureyyapasa Thoracic and Cardiovascular Disease Hospital Istanbul, Turkey
Cengiz Köksal, MD Tel: 90 212 696 8602 Fax: 90 216 352 0954 email: ckoksal{at}hotmail.com Department of Cardiovascular Surgery, Sureyyapasa Thoracic and Cardiovascular Disease Hospital, D-Blok, Basibuyuk, Maltepe, Istanbul 81551, Turkey.

Descending thoracic aorta-to-femoral artery bypass grafting is considered a good alternative procedure for revascularization in cases of aortic graft failure, graft infection, and other intraabdominal pathologies not amenable to standard aortofemoral revascularization. Its use as the primary mode of treatment in selected cases is still under investigation. From January 1998 to June 2001, 5 patients underwent descending thoracic aorta-to-femoral artery bypass grafting as primary treatment for juxtarenal aortic occlusion. There was no operative mortality nor major morbidity; a groin incision infection occurred in one case. The mean hospital stay was 8.2 days and intensive care unit stay was 2.6 days. Graft failure was not encountered in the short-term follow-up. In spite of the small number of patients, it was concluded that thoracic aortofemoral bypass offers excellent inflow and reliable patency and may be considered for primary revascularization in cases of juxtarenal aortic occlusion.